A study to evaluate the performance of the non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) and improve the algorithm in patients who underwent liver transplantation: a prospective observational study
Not Applicable
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0009069
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1. Patients who underwent liver transplant surgery
2. Patients undergoing postoperative hemodynamic monitoring in the surgical intensive care unit (SICU) after liver transplant surgery
3, Adult patients over 20 years old but under 80 years old
Exclusion Criteria
1. Clinically significant arrhythmia (e.g. atrial fibrillation) that may affect stroke volume calculations
2. Patients with a cardiac pacemaker or defibrillator
3. Patients using mechanical circulatory support devices such as arteriovenous extracorporeal oxygenation (VA-ECMO) or intra-aortic balloon pump (IABP) before surgery.
4. Other people deemed unsuitable by researchers
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiac output
- Secondary Outcome Measures
Name Time Method stroke volume